相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma
Alma Demirovic et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Seromic profiling of ovarian and pancreatic cancer
Sacha Gnjatic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Otavia L. Caballero et al.
CANCER SCIENCE (2009)
Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity
Shohei Domae et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Mary L. Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
Kazuhide Tsuji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
Hisashi Wada et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
Sylvia Adams et al.
JOURNAL OF IMMUNOLOGY (2008)
Adenovirus MART-1 - engineered autologous dendritic cell vaccine for metastatic melanoma
Lisa H. Butterfield et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients
Ryohei Kawabata et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Recombinant vaccinia/fowipox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
Elke Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines
Hiroyoshi Nishikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer
EA Mittendorf et al.
SURGERY (2006)
Recombinant NY-ESO-1 cancer antigen: Production and purification under cGMP conditions
R Murphy et al.
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY (2005)
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens
C Germeau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
C Lurquin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors
Y Sugita et al.
CANCER RESEARCH (2004)
NY-ESO-1 expression and immunogenicity in esophageal cancer
S Fujita et al.
CLINICAL CANCER RESEARCH (2004)
Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients
ML Disis et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CD8+ T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients
S Gnjatic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading
KM Lally et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
H Jonuleit et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Induction of primary NY-ESO-1 immunity:: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers
E Jäger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
